Welcome to our dedicated page for Cycurion SEC filings (Ticker: CYCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cycurion, Inc. filings document material-event disclosures for an emerging growth company operating in AI-driven cybersecurity and information technology services. Recent 8-K reports furnish press releases and exhibits covering customer contract awards, operating and financial updates, shareholder communications, acquisition-related disclosures, legal proceedings, and other corporate events.
The company's regulatory record also includes governance disclosures such as board changes, amendments to prior 8-K reports, capital-structure references involving common stock and warrants, and securityholder-facing information tied to its public-company status. These filings frame Cycurion's contract-based revenue model, cybersecurity platforms, legal matters, and corporate actions in formal SEC disclosure.
Cycurion, Inc. Amendment No. 3 to a Schedule 13G/A reports that Alpha Capital Anstalt beneficially owns 210,392 shares of Cycurion common stock, equal to 3.818% of the class. The filing cites 5,509,988 shares outstanding as of March 24, 2026 (reported in the Form 10-K). The filing is signed by Konrad Ackermann as Director on 04/16/2026 and is classified under "Ownership of 5 Percent or Less of a Class."
Cycurion, Inc. files its annual report describing a cybersecurity and AI-powered IT services business focused on government and regulated markets, while warning of substantial doubt about its ability to continue as a going concern due to recurring losses, working capital deficits and high debt.
The company highlights strong demand indicators, including committed backlog rising to $80.0 million as of December 31, 2025 and multiple new contracts such as a $22 million multi-year criminal justice system award and a $6 million municipal contract. It also entered a $1,000,000 stock-for-stock exchange with iQSTEL and declared a $500,000 special stock dividend.
Cycurion details Nasdaq listing challenges and an October 2025 one-for-thirty reverse stock split that reduced outstanding shares to about 2,884,447, regaining minimum bid price compliance but cautioning future delisting risk. As of March 24, 2026, it reports 5,509,988 common shares outstanding and emphasizes dependence on a concentrated government client base, evolving cybersecurity regulations and the need for additional capital, including through a crypto-focused subsidiary.
Cycurion, Inc. reported two new public health sector contract awards that together are expected to generate approximately $1.35 million in revenue in 2026, including about $1.165 million in new annual recurring revenue.
The awards include a multi-year engagement with a large healthcare government agency under a potential 10-year framework and an expanded relationship with the National Association of County and City Health Officials, which is expected to add about $185,000 this year. Cycurion highlighted that these wins reinforce its presence in public health, support its focus on profitable, high-margin recurring revenue, and expand contracted backlog for its cybersecurity and cloud-based public health systems.
Cycurion, Inc. reports that stockholders approved a warrant exercise proposal under Nasdaq Listing Rule 5635(d), authorizing issuance of up to 3,314,920 shares of common stock upon exercise of certain private placement warrants. An adjournment proposal to extend the special meeting, if needed, was also approved.
Cycurion states that a press release claiming an acquisition exceeding $150 million was false and unauthorized, and that related trading volatility, with shares between about $1.00 and $2.40, appears connected to that release. The company is cooperating with FINRA and Nasdaq, has engaged litigation counsel, obtained court subpoenas for two individuals involved in spreading false information, and is pursuing remedies related to possible short selling and stock manipulation. Cycurion cites a verified contracted backlog of $112.4 million and continuing contract wins with federal and enterprise clients.
Cycurion, Inc. adjourned its special meeting of stockholders to March 19, 2026 after the original meeting failed to reach a quorum. The extra time is intended to let more stockholders cast their votes.
A key proposal seeks approval under Nasdaq Listing Rule 5635(d) for the potential issuance of up to 3,314,920 shares of common stock upon exercise of warrants issued in a private placement that closed on December 5, 2025. The record date remains January 21, 2026, previously submitted proxies remain valid unless revoked, and stockholders who have already voted do not need to take further action.
Cycurion, Inc. reports a Schedule 13G filing showing Armistice Capital, LLC and Steven Boyd beneficially own 301,052 shares, representing 9.99% of the company's common stock as of 12/31/2025. The filing states Armistice Capital is the investment manager of Armistice Capital Master Fund Ltd., the direct holder, and that Armistice Capital exercises shared voting and dispositive power over these shares. Steven Boyd is identified as the managing member of Armistice Capital and is reported with shared voting and dispositive power. The Master Fund is noted as the entity with the economic right to dividends or sale proceeds.